You just read:

VISEN Pharmaceuticals announces China Phase 3 clinical study initiation for TransCon human growth hormone, the first unmodified long-acting growth hormone in China

News provided by

VISEN Pharmaceuticals

Oct 25, 2019, 09:24 ET